LKFT
Lakefront Biotherapeutics NVNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.81B
P/E Ratio
3.19
EPS
$8.61
Beta
0.12
52W High
$29.77
52W Low
$26.42
50-Day MA
$29.06
200-Day MA
$31.85
Dividend Yield
—
Profit Margin
46.80%
Forward P/E
344.83
PEG Ratio
—
About Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV (LKFT) is a biopharmaceutical company focused on the development of innovative therapies targeting unmet medical needs, particularly in the fields of oncology and infectious diseases. With a robust pipeline of drug candidates leveraging its proprietary technologies, the company aims to harness the potential of biologics and small molecules to improve patient outcomes. Lakefront Biotherapeutics is committed to advancing its clinical programs and establishing strategic partnerships to enhance its research capabilities and market reach. Through its dedication to scientific excellence and patient-centered approaches, LKFT seeks to become a leader in the biotherapeutics space.
Fundamentals
| Revenue (TTM) | $1.04B |
| Gross Profit (TTM) | $715.32M |
| EBITDA | $662.96M |
| Operating Margin | -983.00% |
| Return on Equity | 16.30% |
| Return on Assets | 10.70% |
| Revenue/Share (TTM) | $0.79 |
| Book Value | — |
| Price-to-Book | 0.48 |
| Price-to-Sales (TTM) | 1.74 |
| EV/Revenue | - |
| EV/EBITDA | -31.50 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -91.40% |
| Shares Outstanding | $65.90M |
| Float | $44.54M |
| % Insiders | 25.35% |
| % Institutions | 22.67% |
Historical Volatility
HV 10-Day
35.53%
HV 20-Day
32.41%
HV 30-Day
27.99%
HV 60-Day
31.41%
HV Rank
42.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($23.31 target)
3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026